文献速递妇科产科

65岁以上HIV感染女性高级别宫颈鳞状病变的频率

Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
PubMed 文献 · Am J Obstet Gynecol · 2021-05-03

本研究基于美国多中心HIV研究队列,分析65岁以上女性高级别宫颈细胞学异常的发生率。共169名女性(121名HIV感染,48名未感染)参与。结果显示,符合停止筛查标准的女性中,HIV感染与未感染者高级别鳞状上皮内病变风险相似,但多数HIV感染者不符合停止筛查标准,需继续筛查。

要点

  • 65岁以上HIV感染女性多数不符合停止宫颈癌筛查标准。
  • 符合停止筛查标准者高级别鳞状病变风险与未感染女性相似。
  • 研究未发现宫颈癌,但高级别细胞学异常发生率为2.2%。

核心结论

  • 多数HIV感染女性不符合停止宫颈癌筛查标准,65岁以上需继续筛查。
  • 符合停止筛查标准的女性高级别鳞状病变风险与未感染HIV女性相似,可选择停止筛查。

研究设计与样本

  • 美国多中心队列研究(Women's Interagency HIV Study),纳入3678名HIV感染女性和1304名未感染女性,分析其中65岁以上女性数据。
  • 每6个月进行巴氏涂片检查,按1991年Bethesda系统判读,主要终点为高级别细胞学异常。

主要发现

  • 169名65岁以上女性中,2.2%有高级别细胞学异常,未发现癌症。

关键数值与推荐

  • 高级别细胞学异常包括高级别鳞状上皮内病变、非典型腺细胞、不能排除高级别病变的非典型鳞状细胞和恶性细胞学。
  • 符合停止筛查标准定义为有宫颈且满足当前指南条件(充分既往筛查且无癌前病变史)。

临床怎么用

  • 对65岁以上HIV感染女性,应评估是否符合停止筛查标准,多数需继续筛查。
  • 符合停止筛查标准者可与未感染HIV女性类似考虑停止筛查。

局限性

  • 样本量较小,尤其符合停止筛查标准者仅48人。
  • 观察时间有限,未发现癌症,需更长随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current US cervical cancer screening guidelines recommend screening cessation at the age of 65 years provided women have adequate previous screening and no history of precancer. Women living with HIV are at higher risk of cervical cancer than women living without HIV. Furthermore, limited data exists to quantify the risk of cervical cancer among women who otherwise would qualify for screening cessation. OBJECTIVE: This study aimed to determine whether guidelines recommending women to discontinue cervical cancer screening at the age of 65 years are appropriate for women living with HIV. STUDY DESIGN: Semiannual Papanicolaou testing was performed as part of surveillance visits in the Women's Interagency HIV Study. Launched in October 1994, the Women's Interagency HIV Study is a federally funded US multisite cohort study that has enrolled 3678 women living with HIV and 1304 women living without HIV; we included data throughout September 2019 onward. Conventional Papanicolaou tests were collected at scheduled 6-month visits and read centrally according to the 1991 Bethesda System criteria. Results were analyzed among women at least 65 years of age. The primary endpoint was high-grade cytology, including high-grade squamous intraepithelial lesions; atypical glandular cells; atypical squamous cells, cannot exclude high-grade lesions; and malignant cytology. Wilcoxon rank-sum tests were used to compare the continuous variables, and Chi-square tests or the Fisher exact tests were used to compare the categorical variables. The Kaplan-Meier method was used to calculate the cumulative incidence. Poisson regression was used to compare 2 incidence rates. RESULTS: Of 169 eligible women (121 women living with HIV and 48 women living without HIV) who contributed 678.4 person-years of observation after reaching the age of 65 years, 2.2% had high-grade cytologic abnormalities. However, no cancer was found. Furthermore, 20 women had previous precancer results, and 74 women had abnormal Papanicolaou test results in the previous decade. Among 50 women (38 women living with HIV and 12 women living without HIV) with a previous hysterectomy and no history of cervical precancer, the cumulative incidence rates of high-grade squamous intraepithelial lesions were 0.6 (95% confidence interval, 0.0-3.2) per 100 person-years for women living with HIV and 0.0 (95% confidence interval, 0.0-8.1) per 100 person-years for women living without HIV (P=.61). Only 48 women (27 women living with HIV and 21 women living without HIV) had cervices and met the current guidelines to discontinue screening; their risk of experiencing high-grade squamous intraepithelial lesions was 2.2 (95% confidence interval, 0.6-5.5) per 100 person-years overall and did not vary by HIV status (2.3 [95% confidence interval, 0.5-6.8] per 100 person-years for women living with HIV and 1.8 [95% confidence interval, 0.0-9.8] per 100 person-years for women living without HIV; P=.81). CONCLUSION: Most women living with HIV do not meet the criteria for cervical cancer screening cessation and will need to continue screening over the age of 65 years; however, women who meet the criteria for screening cessation have risks of high-grade squamous lesions similar to women living without HIV and may choose to discontinue.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Massad LS, Xie X, Minkoff HL, et al. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV. Am J Obstet Gynecol. 2021. PMID: 33957115. doi:10.1016/j.ajog.2021.04.253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。